Healthcare -
Biotechnology - NASDAQ - US
$ 20.815
-2.73 %
$ 1.85 B
Market Cap
-5.11
P/E
TVTX - OPERATING EXPENSES
Operating Expenses TVTX - Travere Therapeutics, Inc.
557 M
LAST VALUE
10.52%
2 YEAR CAGR
15.59%
5 YEAR CAGR
17.89%
10 YEAR CAGR